Wells Fargo’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Buy |
|
|||||
|
2025
Q1 | $202K | Buy |
|
|||||
|
2024
Q4 | $299K | Buy |
|
|||||
|
2024
Q3 | $220K | Sell |
|
|||||
|
2024
Q2 | $204K | Buy |
|
|||||
|
2024
Q1 | $532K | Buy |
|
|||||
|
2023
Q4 | $986K | Buy |
|
|||||
|
2023
Q3 | $653K | Sell |
|
|||||
|
2023
Q2 | $1.68M | Buy |
|
|||||
|
2023
Q1 | $832K | Buy |
|
|||||
|
2022
Q4 | $300K | Buy |
|
|||||
|
2022
Q3 | $187K | Buy |
|
|||||
|
2022
Q2 | $123K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $4.42M | Buy |
|
|||||
|
2021
Q3 | $5.06M | Sell |
|
|||||
|
2021
Q2 | $8.31M | Buy |
|
|||||
|
2021
Q1 | $6.32M | Sell |
|
|||||
|
2020
Q4 | $8.54M | Buy |
|
|||||
|
2020
Q3 | $1.37M | Buy |
|
|||||
|
2020
Q2 | $423K | Buy |
|
|||||
|
2020
Q1 | $288K | Sell |
|
|||||
|
2019
Q4 | $1.75M | Buy |
|
|||||
|
2019
Q3 | $1.29M | Sell |
|
|||||
|
2019
Q2 | $1.52M | Buy |
|
|||||
|
2019
Q1 | $655K | Buy |
|
|||||
|
2018
Q4 | $619K | Buy |
|
|||||
|
2018
Q3 | $377K | Buy |
|
|||||
|
2018
Q2 | $246K | Sell |
|
|||||
|
2018
Q1 | $146K | Sell |
|
|||||
|
2017
Q4 | $374K | Sell |
|
|||||
|
2017
Q3 | $781K | Buy |
|
|||||
|
2017
Q2 | $520K | Sell |
|
|||||
|
2017
Q1 | $1.14M | Buy |
|
|||||
|
2016
Q4 | $506K | Buy |
|
|||||
|
2016
Q3 | $328K | Sell |
|
|||||
|
2016
Q2 | $6.53M | Buy |
|
|||||
|
2016
Q1 | $413K | Buy |
|
|||||
|
2015
Q4 | $572K | Sell |
|
|||||
|
2015
Q3 | $456K | Buy |
|
|||||
|
2015
Q2 | $106K | Sell |
|
|||||
|
2015
Q1 | $139K | Buy |
|
|||||
|
2014
Q4 | $135K | Buy |
|
|||||
|
2014
Q3 | $13K | Sell |
|
|||||
|
2014
Q2 | $25K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $4K | Buy |
|